UBS raised the firm’s price target on Exelon (EXC) to $48 from $46 and keeps a Neutral rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC:
- ComEd receives approval for Beneficial Electrification Plan 2 from ICC
- Exelon price target lowered to $48 from $49 at Morgan Stanley
- Exelon Corp.’s New Ventures: Navigating Risks in Smart Grids and Electrification
- Exelon downgraded to Underweight from Sector Weight at KeyBanc
- Exelon price target raised to $50 from $46 at Wells Fargo
